This is the authors' abstract. We don't add key points for this paper.
The endogenous neuropeptide cholecystokinin, when administered systemically or perispinally, potently antagonizes opiate analgesia produced by foot shock and morphine. Nonopiate foot-shock analgesia is not reduced by this neuropeptide. The spinal cord appears to be a critical site of cholecystokinin action. These experiments suggest a physiological role for cholecystokinin as a specific opiate antagonist in analgesia-mediating systems. A similar mode of action may explain other behavioral effects of cholecystokinin, such as suppression of food intake.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Faris et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: